Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Feb 2026, Mar 2026, Aug 2026 and Sep 2026.
- Largest single sale: $3.4M (125,000 shares) of NewAmsterdam Pharma Co N.V. on Aug 24, 2026. Filing
- Last sale before this period: Aug 22, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Scientific Officer, Director | Dec 29, 2023 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, NewAmsterdam Pharma Co N.V.: sold 50,246 shares for $1.3M, under a disclosed plan; 50,246 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Aug 24, 2026, NewAmsterdam Pharma Co N.V.: sold 125,000 shares for $3.4M, under a disclosed plan; 125,000 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Mar 9, 2026, NewAmsterdam Pharma Co N.V.: sold 101,409 shares for $3.1M, under a disclosed plan; 101,409 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Mar 6, 2026, NewAmsterdam Pharma Co N.V.: sold 94,124 shares for $2.9M, under a disclosed plan; 94,124 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Mar 5, 2026, NewAmsterdam Pharma Co N.V.: sold 104,467 shares for $3.2M, under a disclosed plan; 104,467 shares acquired by exercising options (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.